APA (7th ed.) Citation

P, V., SD, M., J, L., R, M., P, B., S, H., . . . S, T. (2019). Radiotherapy boost in patients with hypoxic lesions identified by 18F-FMISO PET/CT in non-small-cell lung carcinoma: Can we expect a better survival outcome without toxicity? [RTEP5 long-term follow-up]. European journal of nuclear medicine and molecular imaging, 46(7), 1448. https://doi.org/10.1007/s00259-019-04285-9

Chicago Style (17th ed.) Citation

P, Vera, et al. "Radiotherapy Boost in Patients with Hypoxic Lesions Identified by 18F-FMISO PET/CT in Non-small-cell Lung Carcinoma: Can We Expect a Better Survival Outcome Without Toxicity? [RTEP5 Long-term Follow-up]." European Journal of Nuclear Medicine and Molecular Imaging 46, no. 7 (2019): 1448. https://doi.org/10.1007/s00259-019-04285-9.

MLA (9th ed.) Citation

P, Vera, et al. "Radiotherapy Boost in Patients with Hypoxic Lesions Identified by 18F-FMISO PET/CT in Non-small-cell Lung Carcinoma: Can We Expect a Better Survival Outcome Without Toxicity? [RTEP5 Long-term Follow-up]." European Journal of Nuclear Medicine and Molecular Imaging, vol. 46, no. 7, 2019, p. 1448, https://doi.org/10.1007/s00259-019-04285-9.